HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis
- PMID: 37454979
- PMCID: PMC10529779
- DOI: 10.1053/j.gastro.2023.06.034
HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis
Abstract
Background & aims: Ulcerative colitis (UC) is characterized by severe inflammation and destruction of the intestinal epithelium, and is associated with specific risk single nucleotide polymorphisms in HLA class II. Given the recently discovered interactions between subsets of HLA-DP molecules and the activating natural killer (NK) cell receptor NKp44, genetic associations of UC and HLA-DP haplotypes and their functional implications were investigated.
Methods: HLA-DP haplotype and UC risk association analyses were performed (UC: n = 13,927; control: n = 26,764). Expression levels of HLA-DP on intestinal epithelial cells (IECs) in individuals with and without UC were quantified. Human intestinal 3-dimensional (3D) organoid cocultures with human NK cells were used to determine functional consequences of interactions between HLA-DP and NKp44.
Results: These studies identified HLA-DPA1∗01:03-DPB1∗04:01 (HLA-DP401) as a risk haplotype and HLA-DPA1∗01:03-DPB1∗03:01 (HLA-DP301) as a protective haplotype for UC in European populations. HLA-DP expression was significantly higher on IECs of individuals with UC compared with controls. IECs in human intestinal 3D organoids derived from HLA-DP401pos individuals showed significantly stronger binding of NKp44 compared with HLA-DP301pos IECs. HLA-DP401pos IECs in organoids triggered increased degranulation and tumor necrosis factor production by NKp44+ NK cells in cocultures, resulting in enhanced epithelial cell death compared with HLA-DP301pos organoids. Blocking of HLA-DP401-NKp44 interactions (anti-NKp44) abrogated NK cell activity in cocultures.
Conclusions: We identified an UC risk HLA-DP haplotype that engages NKp44 and activates NKp44+ NK cells, mediating damage to intestinal epithelial cells in an HLA-DP haplotype-dependent manner. The molecular interaction between NKp44 and HLA-DP401 in UC can be targeted by therapeutic interventions to reduce NKp44+ NK cell-mediated destruction of the intestinal epithelium in UC.
Keywords: HLA-DP; Intestinal Organoids; NK Cells; NKp44; Ulcerative Colitis.
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Interests
A.N. and M.A. are inventors of one provisional patent that describes the binding of NKp44 to a subset of HLA-DP molecules, and the role of these interactions in Graft versus Host Disease. All other authors declare no conflicts of interest.
Figures





Similar articles
-
HLA-DPA1*02:01~B1*01:01 is a risk haplotype for primary sclerosing cholangitis mediating activation of NKp44+ NK cells.Gut. 2024 Jan 5;73(2):325-337. doi: 10.1136/gutjnl-2023-329524. Gut. 2024. PMID: 37788895 Free PMC article.
-
A subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44.Nat Immunol. 2019 Sep;20(9):1129-1137. doi: 10.1038/s41590-019-0448-4. Epub 2019 Jul 29. Nat Immunol. 2019. PMID: 31358998 Free PMC article.
-
NKp44/HLA-DP-dependent regulation of CD8 effector T cells by NK cells.Cell Rep. 2024 Apr 23;43(4):114089. doi: 10.1016/j.celrep.2024.114089. Epub 2024 Apr 13. Cell Rep. 2024. PMID: 38615318 Free PMC article.
-
Generation and expression analysis of BAC humanized mice carrying HLA-DP401 haplotype.Animal Model Exp Med. 2021 Mar 23;4(2):116-128. doi: 10.1002/ame2.12158. eCollection 2021 Jun. Animal Model Exp Med. 2021. PMID: 34179719 Free PMC article.
-
NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans.Front Immunol. 2019 Apr 9;10:719. doi: 10.3389/fimmu.2019.00719. eCollection 2019. Front Immunol. 2019. PMID: 31024551 Free PMC article. Review.
Cited by
-
Relationship between the risk of intestinal mucosal Epstein-Barr virus and/or cytomegalovirus infection and peripheral blood NK cells numbers in patients with ulcerative colitis: a cross-sectional study in Chinese population.Front Microbiol. 2024 Dec 4;15:1498483. doi: 10.3389/fmicb.2024.1498483. eCollection 2024. Front Microbiol. 2024. PMID: 39697654 Free PMC article.
-
Ulcerative colitis: molecular insights and intervention therapy.Mol Biomed. 2024 Oct 10;5(1):42. doi: 10.1186/s43556-024-00207-w. Mol Biomed. 2024. PMID: 39384730 Free PMC article. Review.
-
HLA-DPA1*02:01~B1*01:01 is a risk haplotype for primary sclerosing cholangitis mediating activation of NKp44+ NK cells.Gut. 2024 Jan 5;73(2):325-337. doi: 10.1136/gutjnl-2023-329524. Gut. 2024. PMID: 37788895 Free PMC article.
-
Fifty years of HLA-associated type 1 diabetes risk: history, current knowledge, and future directions.Front Immunol. 2024 Sep 12;15:1457213. doi: 10.3389/fimmu.2024.1457213. eCollection 2024. Front Immunol. 2024. PMID: 39328411 Free PMC article. Review.
-
Organoids in gastrointestinal diseases: from bench to clinic.MedComm (2020). 2024 Jun 29;5(7):e574. doi: 10.1002/mco2.574. eCollection 2024 Jul. MedComm (2020). 2024. PMID: 38948115 Free PMC article. Review.
References
-
- Boer NKH de, Ahuja V, Almer S, et al. Thiopurine Therapy in Inflammatory Bowel Diseases: Making New Friends Should Not Mean Losing Old Ones. Gastroenterology 2019;156. - PubMed
-
- Al-Horani R, Spanudakis E, Hamad B. The market for ulcerative colitis. Nat Rev Drug Discov 2022;21. - PubMed
-
- Panaccione R, Ghosh S, Middleton S, et al. Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis. Gastroenterology 2014;146. - PubMed
-
- Kobayashi T, Siegmund B, Berre C Le, et al. Ulcerative colitis. Nat Rev Dis Prim 2020;6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials